These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8025906)
1. Cardiovascular effects of a non-xanthine-selective antagonist of the A1 adenosine receptor in the anaesthetised pig: pharmacological and therapeutic implications. Sidi A; Wesley R; Barrett R; Rush W; Belardinelli L Cardiovasc Res; 1994 May; 28(5):621-8. PubMed ID: 8025906 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of N-0861, (+-)-N6-endonorbornan-2-yl-9-methyladenine, as an A1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart. Shryock JC; Travagli HC; Belardinelli L J Pharmacol Exp Ther; 1992 Mar; 260(3):1292-9. PubMed ID: 1545393 [TBL] [Abstract][Full Text] [Related]
3. Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans. Bertolet BD; Belardinelli L; Franco EA; Nichols WW; Kerensky RA; Hill JA Circulation; 1996 May; 93(10):1871-6. PubMed ID: 8635266 [TBL] [Abstract][Full Text] [Related]
4. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria. Martin PL; Potts AA; Sykes AM; McKenna DG J Pharmacol Exp Ther; 1993 Apr; 265(1):201-6. PubMed ID: 8474007 [TBL] [Abstract][Full Text] [Related]
5. Effect of N-0861, a selective adenosine A1 receptor antagonist, on pharmacologic stress imaging with adenosine. Glover DK; Ruiz M; Sansoy V; Barrett RJ; Beller GA J Nucl Med; 1995 Feb; 36(2):270-5. PubMed ID: 7830130 [TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta. Martin PL; May JM J Pharmacol Exp Ther; 1994 Jun; 269(3):1228-35. PubMed ID: 8014866 [TBL] [Abstract][Full Text] [Related]
8. Effects of N6-endonorbornan-2-yl-9-methyladenine, N0861, on negative chronotropic and vasodilatory actions of adenosine in the canine heart in vivo. Pelleg A; Hurt CM Can J Physiol Pharmacol; 1992 Nov; 70(11):1450-6. PubMed ID: 1296857 [TBL] [Abstract][Full Text] [Related]
9. Effect of selective A1 adenosine receptor antagonism of postdefibrillation cardiovascular depression: evidence for an antiadrenergic role of endogenous adenosine. Wesley RC; Porzio D; Sadeghi M Cardiovasc Res; 1993 Jan; 27(1):129-33. PubMed ID: 8458023 [TBL] [Abstract][Full Text] [Related]
10. Evidence that adenosine receptors in the dog left atrium are not of the typical A1 or A2 adenosine receptor subtypes. Martin PL Eur J Pharmacol; 1992 Apr; 214(2-3):199-205. PubMed ID: 1516639 [TBL] [Abstract][Full Text] [Related]
11. ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog. Akatsuka Y; Egashira K; Katsuda Y; Narishige T; Ueno H; Shimokawa H; Takeshita A Cardiovasc Res; 1994 Jun; 28(6):906-11. PubMed ID: 7923297 [TBL] [Abstract][Full Text] [Related]
12. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig. Martin PL; Ueeda M; Olsson RA J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010 [TBL] [Abstract][Full Text] [Related]
13. A selective adenosine A1 receptor antagonist attenuates renal dysfunction during controlled hypotension with adenosine in rats. Barrett RJ; Wright KF Anesth Analg; 1994 Sep; 79(3):460-5. PubMed ID: 8067549 [TBL] [Abstract][Full Text] [Related]
14. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors. Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314 [TBL] [Abstract][Full Text] [Related]
15. Adenosine analogues prevent phorbol ester-induced PKC depletion in porcine coronary artery via A1 receptor. Marala RB; Mustafa SJ Am J Physiol; 1995 Jan; 268(1 Pt 2):H271-7. PubMed ID: 7840272 [TBL] [Abstract][Full Text] [Related]
16. Differential antagonism of cardiac actions of adenosine by theophylline. Bertolet BD; Belardinelli L; Avasarala K; Calhoun WB; Franco EA; Nichols WW; Kerensky RA; Hill JA Cardiovasc Res; 1996 Nov; 32(5):839-45. PubMed ID: 8944814 [TBL] [Abstract][Full Text] [Related]
17. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig. Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130 [TBL] [Abstract][Full Text] [Related]
18. Interstitial adenosine and function in rat heart in vivo: effects of adrenaline and 8-cyclopentyl-1,3-dimethylxanthine. Headrick JP Clin Exp Pharmacol Physiol; 1996 May; 23(5):386-94. PubMed ID: 8713676 [TBL] [Abstract][Full Text] [Related]
19. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells. Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078 [TBL] [Abstract][Full Text] [Related]